Arrive AI is betting its patent-led “last-inch” delivery endpoint network can become the universal autonomous handoff standard—before dilution and delisting risk run out the clock.
Overview
Arrive AI (ARAI), formerly Dronedek, is an early-stage autonomous logistics infrastructure company focused on the “last inch” of last-mile delivery: the standardized, secure exchange point between any delivery vehicle (human, robot, drone) and the recipient environment. Rather than competing with drone or robot manufacturers, it aims to be the carrier-agnostic endpoint network—Arrive Points™—paired with a subscription software layer (ALM platform) that orchestrates storage-slot reservations, real-time tracking, safety monitoring, and chain-of-custody verification. The company’s commercial model is hardware-enabled recurring revenue (Mailbox-as-a-Service / Network-as-a-Service), designed to avoid customer capex and create predictable ARPU per installed unit. FY2025 represented the first year of meaningful commercial activity, generating ~$113,250 of revenue—reported as 100% recurring subscription revenue—primarily from healthcare pilots (notably Hancock Health), which is the lead vertical due to high-value, time-sensitive, and regulated shipments. Product development is transitioning from AP3 to AP5 to improve scalability and economics by internalizing engineering and reducing BOM, while integrating AI-enabled sensors (e.g., ToF/depth) that enable precise autonomous docking “handshakes.” Strategically, the company emphasizes its patent portfolio (10 issued U.S. patents, “First Position,” and a shared-use patent) as a defensive moat and a potential toll-gate if autonomous delivery scales broadly. Despite a large theoretical TAM, the investment case is currently dominated by execution risk, liquidity constraints, and dilution risk tied to structured financing.